Genetic testing confirms Charcot-Marie-Tooth type 4C in five patients misdiagnosed with CIDP due to electrodiagnostic pitfalls
Background
Charcot-Marie-Tooth disease type 4C (CMT4C) is a hereditary neuropathy caused by recessive mutations in the SH3TC2 gene, leading to progressive nerve damage. Distinguishing CMT4C from acquired conditions like Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is challenging due to overlapping clinical and electrophysiological symptoms. Misdiagnosis can result in ineffective treatments and prolonged patient suffering. This study addresses the critical need for accurate differentiation to guide appropriate management and avoid unnecessary therapies for presumed immune-mediated neuropathies.
Study Design
This study retrospectively analyzed the clinical and electrophysiological profiles of five patients who were initially misdiagnosed with CIDP but later confirmed to have CMT4C. Data collected included demographics, detailed clinical features (e.g., muscle weakness, spinal deformities), nerve conduction studies (NCS), and nerve ultrasonographic findings. All patients subsequently underwent genetic testing to identify pathogenic SH3TC2 variants, serving as the definitive diagnostic method to confirm CMT4C and differentiate it from CIDP.
Results
All five patients exhibited early-onset symptoms, including progressive muscle weakness, pes cavus, and spinal deformities like scoliosis; some had a positive family history, while others appeared sporadic. Nerve conduction studies consistently revealed diminished motor and sensory amplitudes and conduction velocities. Crucially, findings initially interpreted as conduction block or temporal dispersion were reappraised as "temporal dispersion-related pseudo-block" in the tibial nerves, a key electrodiagnostic pitfall leading to misdiagnosis. Genetic testing confirmed pathogenic SH3TC2 mutations in all 5 cases, providing the definitive diagnosis. Nerve ultrasonography showed an increase in cross-sectional area (CSA), indicating nerve hypertrophy, a characteristic observed in both CMT and CIDP. This finding alone was insufficient to differentiate the conditions. > The presence of "temporal dispersion-related pseudo-block" in tibial nerves was a critical electrodiagnostic finding that contributed to the initial misdiagnosis of CIDP.
Key Findings
- Five patients initially misdiagnosed with CIDP were genetically confirmed to have CMT4C.
- Initial
nerve conduction studiesshowed "temporal dispersion-related pseudo-block" in tibial nerves, contributing to misdiagnosis. - All 5 patients had pathogenic
SH3TC2mutations confirmed by genetic testing. Nerve ultrasonographyrevealed increasedcross-sectional area (CSA), a non-specific finding in both CMT and CIDP.- Key clues for CMT4C include early onset, parental consanguinity, scoliosis, and poor response to immunotherapy.
Why It Matters
Accurate distinction between CMT4C and CIDP is paramount to prevent patients from receiving ineffective and potentially harmful treatments for an immune-mediated condition. Clinicians should consider genetic testing in refractory or atypical cases of presumed immune-mediated neuropathy. This study highlights specific clinical clues that should prompt genetic investigation, including early symptom onset, parental consanguinity, spinal deformities like scoliosis, and a poor or absent response to immunotherapy. Integrating these clues with electrodiagnostic findings can significantly improve diagnostic accuracy, leading to correct diagnoses and avoiding unnecessary therapeutic interventions, thereby improving patient outcomes and resource allocation.
charcot-marie-tooth
cmt4c
cidp
neuropathy
genetic-testing
sh3tc2